This federal contract award, valued at $2,809.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order contract to procure AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, with a firm fixed price. The contract has an ultimate completion date of December 27, 2024.
This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
The contract award was not designated with any set-aside requirements, indicating open competition. Amerisourcebergen is a for-profit organization and a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.
Generated 3/27/25, 9:45 AM